{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:45:25Z","timestamp":1792028725639,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T00:00:00Z","timestamp":1291248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00259-010-1664-1","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T16:12:08Z","timestamp":1291219928000},"page":"764-773","source":"Crossref","is-referenced-by-count":74,"title":["SPECT imaging evaluation in movement disorders: far beyond visual assessment"],"prefix":"10.1007","volume":"38","author":[{"given":"Kosmas","family":"Badiavas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Molyvda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Iakovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalini","family":"Tsolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakos","family":"Psarrakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Karatzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,2]]},"reference":[{"key":"1664_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0031-6997(25)07154-6","volume":"18","author":"O Hornykiewicz","year":"1966","unstructured":"Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925\u201364.","journal-title":"Pharmacol Rev"},{"key":"1664_CR2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1664_CR3","first-page":"88","volume":"30","author":"HF Kung","year":"1989","unstructured":"Kung HF, Pan S, Kung MP, Billings J, Kasliwal R, Reilley J, et al. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. J Nucl Med 1989;30:88\u201392.","journal-title":"J Nucl Med"},{"key":"1664_CR4","first-page":"573","volume":"31","author":"HF Kung","year":"1990","unstructured":"Kung HF, Alavi A, Chang W, Kung MP, Keyes JW, Velchik MG, et al. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med 1990;31:573\u20139.","journal-title":"J Nucl Med"},{"key":"1664_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/jcbfm.1991.53","volume":"11","author":"T Br\u00fccke","year":"1991","unstructured":"Br\u00fccke T, Podreka I, Angelberger P, Wenger S, Topitz A, K\u00fcfferle B, et al. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 1991;11:220\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1664_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00006231-199108000-00005","volume":"12","author":"K Tatsch","year":"1991","unstructured":"Tatsch K, Schwartz J, Oertel WH, Kirsch CM. SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson\u2019s syndrome and Wilson\u2019s disease. Nucl Med Commun 1991;12:699\u2013707.","journal-title":"Nucl Med Commun"},{"key":"1664_CR7","first-page":"764","volume":"35","author":"JP Seibyl","year":"1994","unstructured":"Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi S, et al. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-\u03b2-CIT in healthy human subjects. J Nucl Med 1994;35:764\u201370.","journal-title":"J Nucl Med"},{"key":"1664_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1997;62:133\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1664_CR9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s007020050124","volume":"105","author":"S Asenbaum","year":"1998","unstructured":"Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Br\u00fccke T. [123I]beta-CIT and SPECT in essential tremor and Parkinson\u2019s disease. J Neural Transm 1998;105:1213\u201328.","journal-title":"J Neural Transm"},{"issue":"2","key":"1664_CR10","first-page":"81","volume":"8","author":"G Gerasimou","year":"2005","unstructured":"Gerasimou G, Tsolaki M, Bostanjopoulou S, Liaros G, Papanastasiou E, Balaris V, et al. Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor. Hell J Nucl Med 2005;8(2):81\u20135.","journal-title":"Hell J Nucl Med"},{"issue":"12","key":"1664_CR11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/mds.10592","volume":"18","author":"V Marshall","year":"2003","unstructured":"Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003;18(12):1415\u201323.","journal-title":"Mov Disord"},{"key":"1664_CR12","doi-asserted-by":"crossref","first-page":"BP23","DOI":"10.1007\/s00259-002-0814-5","volume":"29","author":"K Tatsch","year":"2002","unstructured":"Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, et al. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands. Eur J Nucl Med Mol Imaging 2002;29:BP23\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00259-009-1265-z","volume":"37","author":"K Laere Van","year":"2010","unstructured":"Van Laere K, Varone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT\/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37:434\u201342. doi: 10.1007\/s00259-009-1265-z .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR14","doi-asserted-by":"crossref","first-page":"BP30","DOI":"10.1007\/s00259-002-0814-5","volume":"29","author":"K Tatsch","year":"2002","unstructured":"Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, et al. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. Eur J Nucl Med Mol Imaging 2002;29:BP30\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37:443\u201350. doi: 10.1007\/s00259-009-1267-x .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00259-007-0375-8","volume":"34","author":"W Koch","year":"2007","unstructured":"Koch W, Hamann C, Radau PE, Tatsch K. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? Eur J Nucl Med Mol Imaging 2007;34:1265\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/BF00833017","volume":"16","author":"DC Costa","year":"1990","unstructured":"Costa DC, Verhoeff NPLG, Cullum ID, Ell PJ, Syed GM, Barrett J, et al. In vivo characterization of 3-iodo-6-methoxybenzamide 123I in humans. Eur J Nucl Med 1990;16:813\u20136.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR18","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/jm00114a027","volume":"34","author":"JL Neumeyer","year":"1991","unstructured":"Neumeyer JL, Wang S, Millius RA, Baldwin RM, Zia-Ponce Y, Hoffer PB, et al. [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991;34:3144\u20136.","journal-title":"J Med Chem"},{"key":"1664_CR19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF00180909","volume":"20","author":"JT Kuikka","year":"1993","unstructured":"Kuikka JT, Bergstr\u00f6m KA, Vanninen E, Laulumaa V, Hartikainen P, L\u00e4nsimies E. Initial experience with single-photon emission tomography using iodine-123-labelled 2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)tropane in human brain. Eur J Nucl Med 1993;20:783\u20136.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410380407","volume":"38","author":"JP Seibyl","year":"1995","unstructured":"Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, et al. Decreased single-photon emission computed tomographic [123I]\u03b2-CIT striatal uptake correlates with symptom severity in Parkinson\u2019s disease. Ann Neurol 1995;38:589\u201398.","journal-title":"Ann Neurol"},{"key":"1664_CR21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/BF01254479","volume":"23","author":"HF Kung","year":"1996","unstructured":"Kung HF, Kim HJ, Kung MP, Meegalla SK, Pl\u00f6ssl K, Lee HK. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 1996;23:1527\u201330.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002590050374","volume":"26","author":"J Booij","year":"1999","unstructured":"Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 1999;26:171\u201382.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR23","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.90.24.11965","volume":"90","author":"RB Innis","year":"1993","unstructured":"Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A 1993;90:11965\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1664_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF01728311","volume":"24","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolter EC, et al. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson\u2019s disease. Eur J Nucl Med 1997;24:68\u201371.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s007020070077","volume":"107","author":"W Staffen","year":"2000","unstructured":"Staffen W, Mair A, Unterrainer J, Trinka E, Ladurner G. Measuring the progression of idiopathic Parkinson\u2019s disease with [123I] beta-CIT SPECT. J Neural Transm 2000;107:543\u201352.","journal-title":"J Neural Transm"},{"key":"1664_CR26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503\u201310.","journal-title":"Mov Disord"},{"key":"1664_CR27","first-page":"1","volume":"38","author":"S Asenbaum","year":"1997","unstructured":"Asenbaum S, Br\u00fccke T, Pirker W, Podreka I, Angelberger P, Wenger S, et al. Imaging of dopamine transporters with iodine-123-\u03b2-CIT and SPECT in Parkinson\u2019s disease. J Nucl Med 1997;38:1\u20136.","journal-title":"J Nucl Med"},{"key":"1664_CR28","first-page":"2076","volume":"34","author":"NP Verhoeff","year":"1993","unstructured":"Verhoeff NP, Kapucu O, Sokole-Busemann E, van Royen EA, Janssen AG. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability. J Nucl Med 1993;34:2076\u201384.","journal-title":"J Nucl Med"},{"key":"1664_CR29","first-page":"755","volume":"42","author":"M Ichise","year":"2001","unstructured":"Ichise M, Meyer JH, Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med 2001;42:755\u201363.","journal-title":"J Nucl Med"},{"key":"1664_CR30","first-page":"1091","volume":"40","author":"JB Habraken","year":"1999","unstructured":"Habraken JB, Booij J, Slomka P, Sokole EB, van Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 1999;40:1091\u20137.","journal-title":"J Nucl Med"},{"key":"1664_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","volume":"28","author":"J Booij","year":"2001","unstructured":"Booij J, Speelman JD, Horstink MWIM, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001;28:266\u201372.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR32","first-page":"1453","volume":"38","author":"JP Seibyl","year":"1997","unstructured":"Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, et al. Test\/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson\u2019s patients. J Nucl Med 1997;38:1453\u20139.","journal-title":"J Nucl Med"},{"key":"1664_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006231-199901000-00012","volume":"20","author":"JL Baulieu","year":"1999","unstructured":"Baulieu JL, Ribeiro MJ, Levilon-Prunier C, Tranquart F, Chartier JR, Guilloteau D, et al. Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using 123I-iodolisuride SPET. Nucl Med Commun 1999;20:77\u201384.","journal-title":"Nucl Med Commun"},{"issue":"Suppl 2","key":"1664_CR34","first-page":"S399","volume":"37","author":"K Badiavas","year":"2010","unstructured":"Badiavas K, Iakovou I, Molyvda E, et al. Creation of a customized normal database for 123I-FP-CIT SPECT studies in a major nuclear medicine department in Northern Greece. Eur J Nucl Med Mol Imaging 2010;37 Suppl 2:S399.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.wco.0000173141.74137.63","volume":"18","author":"K Seppi","year":"2005","unstructured":"Seppi K, Schocke MFH. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol 2005;18:370\u20135.","journal-title":"Curr Opin Neurol"},{"key":"1664_CR36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0895-6111(00)00045-8","volume":"25","author":"M Koole","year":"2001","unstructured":"Koole M, Laere KV, de Walle RV, Vandenberghe S, Bouwens L, Lernahieu I, et al. MRI guided segmentation and quantification of SPECT images of the basal ganglia: a phantom study. Comput Med Imaging Graph\u00a02001;25:165\u201372.","journal-title":"Comput Med Imaging Graph"},{"key":"1664_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.compmedimag.2006.10.002","volume":"31","author":"GM Rojas","year":"2007","unstructured":"Rojas GM, Raff U, Quintana JC, Huete I, Hutchinson M. Image fusion in neuroradiology: three clinical examples including MRI of Parkinson disease. Comput Med Imaging Graph\u00a02007;31:17\u201327.","journal-title":"Comput Med Imaging Graph"},{"key":"1664_CR38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2967\/jnumed.107.045518","volume":"49","author":"NJ Wee van der","year":"2008","unstructured":"van der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG. Increased serotonin and dopamine transporter binding in psychotropic medication-na\u00efve patients with generalized social anxiety disorder shown by 123I-\u03b2-(4-iodophenyl)-tropane SPECT. J Nucl Med 2008;49:757\u201363.","journal-title":"J Nucl Med"},{"key":"1664_CR39","doi-asserted-by":"crossref","first-page":"N227","DOI":"10.1088\/0031-9155\/49\/14\/N03","volume":"49","author":"JS Fleming","year":"2004","unstructured":"Fleming JS, Bolt L, Stratford JS, Kemp PM. The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol 2004;49:N227\u201334.","journal-title":"Phys Med Biol"},{"key":"1664_CR40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","volume":"33","author":"L Tossici-Bolt","year":"2006","unstructured":"Tossici-Bolt L, Hoffmann SMA, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging 2006;33:1491\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1664_CR41","first-page":"252","volume":"4","author":"AA Dobbeleir","year":"2005","unstructured":"Dobbeleir AA, Hambye AE, Vervaet AM, Ham HR. Quantification of iodine-123-FP-CIT SPECT with a resolution-independent method. World J Nucl Med 2005;4(4):252\u201361.","journal-title":"World J Nucl Med"},{"key":"1664_CR42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/MNM.0b013e32829152c9","volume":"28","author":"I Goethals","year":"2007","unstructured":"Goethals I, Dobbeleir A, Ham H, Santens P, D\u2019Asseler Y. Validation of a resolution-independent method for the quantification of 123I-FP-CIT SPECT scans. Nucl Med Commun 2007;28:771\u20134.","journal-title":"Nucl Med Commun"},{"key":"1664_CR43","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00259-002-0938-7","volume":"29","author":"A L\u00f8kkegaard","year":"2002","unstructured":"L\u00f8kkegaard A, Werdelin LM, Friberg L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur J Nucl Med Mol Imaging 2002;29:1623\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR44","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00006231-200512000-00014","volume":"26","author":"RJ Morton","year":"2005","unstructured":"Morton RJ, Guy MJ, Marshall CA, Clarke EA, Hinton PJ. Variation of DaTSCAN quantification between different gamma camera types. Nucl Med Commun 2005;26:1131\u20137.","journal-title":"Nucl Med Commun"},{"key":"1664_CR45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00006231-200512000-00015","volume":"26","author":"RJ Morton","year":"2005","unstructured":"Morton RJ, Guy MT, Clauss R, Hinton PJ, Marshall CA, Clarke EA. Comparison of different methods of DatSCAN quantification. Nucl Med Commun 2005;26:1139\u201346.","journal-title":"Nucl Med Commun"},{"key":"1664_CR46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nucmedbio.2007.02.008","volume":"34","author":"JD Lee","year":"2007","unstructured":"Lee JD, Huang CH, Weng YH, Lin KJ, Chen CT. An automatic MRI\/SPECT registration algorithm using image intensity and anatomical feature as matching characters: application on the evaluation of Parkinson\u2019s disease. Nucl Med Biol 2007;34:447\u201357.","journal-title":"Nucl Med Biol"},{"key":"1664_CR47","doi-asserted-by":"crossref","unstructured":"Lee JD, Chen CW, Huang CH. Computer-aided evaluation system for Parkinson\u2019s disease using image registration and labeling. Proceedings of the 29th Annual International Conference of the IEEE EMBS. 2007: 844\u20137.","DOI":"10.1109\/IEMBS.2007.4352422"},{"key":"1664_CR48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2967\/jnumed.106.037432","volume":"48","author":"IG Zubal","year":"2007","unstructured":"Zubal IG, Early M, Yuan O, Jennings D, Marek K, Seibyl JP. Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson\u2019s disease patients. J Nucl Med 2007;48:857\u201364.","journal-title":"J Nucl Med"},{"key":"1664_CR49","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-006-0357-2","volume":"34","author":"P Calvini","year":"2007","unstructured":"Calvini P, Rodriguez G, Inguglia F, Mignone A, Guerra UP, Nobili F. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging 2007;34:1240\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR50","volume-title":"Co-planar stereotaxic atlas of the human brain","author":"J Talairach","year":"1988","unstructured":"Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988."},{"key":"1664_CR51","first-page":"220","volume":"41","author":"PE Radau","year":"2000","unstructured":"Radau PE, Linke R, Slomka PJ, Tatsch K. Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med 2000;41:220\u20137.","journal-title":"J Nucl Med"},{"key":"1664_CR52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006231-200501000-00007","volume":"26","author":"G P\u00f6pperl","year":"2005","unstructured":"P\u00f6pperl G, Radau P, Linke R, Hahn K, Tatsch K. Diagnostic performance of a 3-D automated quantification method of dopamine D2 receptor SPECT studies in the differential diagnosis of parkinsonism. Nucl Med Commun 2005;26:39\u201343.","journal-title":"Nucl Med Commun"},{"key":"1664_CR53","first-page":"1109","volume":"46","author":"W Koch","year":"2005","unstructured":"Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46:1109\u201318.","journal-title":"J Nucl Med"},{"key":"1664_CR54","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.mnm.0000243369.80765.24","volume":"27","author":"D Hamilton","year":"2006","unstructured":"Hamilton D, List A, Butler T, Hogg S, Cawley M. Discrimination between parkinsonian syndrome and essential tremor using artificial neural network classification of quantified DaTSCAN data. Nucl Med Commun 2006;27:939\u201344.","journal-title":"Nucl Med Commun"},{"key":"1664_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hbm.460030303","volume":"3","author":"KJ Friston","year":"1995","unstructured":"Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RS. Spatial registration and normalization of images. Hum Brain Mapp 1995;3:165\u201389.","journal-title":"Hum Brain Mapp"},{"key":"1664_CR56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hbm.460020402","volume":"2","author":"KJ Friston","year":"1994","unstructured":"Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RS. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1994;2:189\u2013210.","journal-title":"Hum Brain Mapp"},{"key":"1664_CR57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/brain\/awh485","volume":"128","author":"C Scherfler","year":"2005","unstructured":"Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, et al. Voxel-wise analysis of [123I]\u03b2-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson\u2019s disease. Brain 2005;128:1605\u201312.","journal-title":"Brain"},{"key":"1664_CR58","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.63.8.1154","volume":"63","author":"K Seppi","year":"2006","unstructured":"Seppi K, Scherfler C, Donnemiller E, Virgolini I, Schocke MF, Goebel G, et al. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]\u03b2-CIT SPECT analysis. Arch Neurol 2006;63:1154\u201360.","journal-title":"Arch Neurol"},{"issue":"3","key":"1664_CR59","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuroimage.2004.06.045","volume":"23","author":"SJ Colloby","year":"2004","unstructured":"Colloby SJ, O\u2019Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, et al. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer\u2019s disease and Parkinson\u2019s disease. Neuroimage 2004;23(3):956\u201366.","journal-title":"Neuroimage"},{"key":"1664_CR60","first-page":"1528","volume":"35","author":"S Minoshima","year":"1994","unstructured":"Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528\u201337.","journal-title":"J Nucl Med"},{"key":"1664_CR61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-004-1576-z","volume":"32","author":"K Hosaka","year":"2005","unstructured":"Hosaka K, Ishii K, Sakamoto S, Sadato N, Fukuda H, Kato T, et al. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT. Eur J Nucl Med Mol Imaging 2005;32:92\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"1664_CR62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF02987257","volume":"20","author":"S Takada","year":"2006","unstructured":"Takada S, Yoshimura M, Shindo H, Saito K, Koizumi K, Utsumi H, et al. New semiquantitative assessment of 123I-FP-CIT by an anatomical standardization method. Ann Nucl Med 2006;20(7):477\u201384.","journal-title":"Ann Nucl Med"},{"key":"1664_CR63","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00259-006-0067-9","volume":"33","author":"R Buchert","year":"2006","unstructured":"Buchert R, Berding G, Wilke F, Martin B, von Borczyskowski D, Mester J, et al. IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies. Eur J Nucl Med Mol Imaging 2006;33:1073\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1664_CR64","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s002590050473","volume":"26","author":"PD Acton","year":"1999","unstructured":"Acton PD, Mozley PD, Kung HF. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson\u2019s disease. Eur J Nucl Med 1999;26:1413\u201323.","journal-title":"Eur J Nucl Med"},{"key":"1664_CR65","first-page":"1091","volume":"40","author":"JB Habraken","year":"1999","unstructured":"Habraken JB, Booji J, Slomka P, Sokole EB, van Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automated algorithm. J Nucl Med 1999;40:1091\u20137.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1664-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1664-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1664-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:32:24Z","timestamp":1740738744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1664-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,2]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1664-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,2]]}}}